LaMerieBiologics PipelineReview.com
R&D and Business News Volume 4, Issue 47 November 28, 2011
Ç×ü
FDA ¸®Á¦³×·ÐÀÇ ½À½Ä ³ëÀμºÈ²¹Ýº¯¼º¿¡ VEGF Trap-Eye Çã°¡
¸®Á¦³×·Ð»ç´Â US FDA°¡ ½Å»ý(½À½Ä) ³ëÀμº Ȳ¹ÝÅðÇ༺¿¡ ù12ÁÖµ¿¾È ¸Å4ÁÖ¸¶´Ù 2 ¹Ì¸®±×¶÷ÀÇ ±Ç°í¿ë·®À¸·Î ±× ´ÙÀ½¿¡´Â 2°³¿ù¸¶´Ù 2¹Ì¸®±×¶÷À¸·Î VEGF Trap-Eye·Î½á °úÇÐÁö¿¡ ¾Ë·ÁÁø EYLEA(aflibercept)Áֻ縦 Çã°¡Çß´Ù. EYLEAÀÇ Çã°¡´Â ¿ì¼±±Ç°ËÅ並 ºÎ¿©¹Þ¾Ò´Ù. ÀÌ Çã°¡´Â 2°³ÀÇ ÀÓ»ó 3»ó¿¬±¸ÀÇ °á°ú¿¡ ±Ù°ÅÇÑ °ÍÀÌ´Ù. ÀÌ ¿¬±¸¿¡¼ EYLEA´Â ¸Å 8ÁÖ¸¶´Ù Åõ¿©¸¦ Çؼ 3¹øÀÇ Ãʱ⠸ſù ÁÖ»ç´Â 52ÁÖ¿¡ °ÉÃÄ ½Ã°¢Àû(´«°Ë»çÇ¥¿¡¼ 15°³ÀÇ ±ÛÀÚº¸´Ù Àû°Ô ½Ã·Â»ó½ÇÇÑ °Í)¿¹¹Î¼º À¯ÁöÀÇ ÀÏÂ÷ Á¾°áÁ¡¿¡ ÃøÁ¤µÈ 4ÁÖ¸¶´Ù Åõ¿©ÇÏ´Â Lucentis(ranibizumab) ÁÖ»çÀÇ Ç¥ÁØóġ¿Í ÀÓ»óÀûÀ¸·Î µ¿µîÇÏ´Ù.
http://www.pipelinereview.com/index.php/2011111946354/Antibodies/Regeneron-Announces-FDA-Approval-of-EYLEA-Aflibercept-Injection-for-the-Treatment-of-Wet-Age-Related-Macular-Degeneration.html